Epidermal growth factor (EGF) promotes chemomigration of a human prostate tumor cell line, and EGF immunoreactive proteins are present at sites of metastasis in the stroma of lymph nodes and medullary bone

Prostate

Volumn 28, Issue 1, 1996, Pages 1-9

  Rajan, Rishi ^a   Vanderslice, Rick ^a   Kapur, Shakti ^a   Lynch, John ^a   Thompson, Rik ^a,b   Djakiew, Daniel ^a,b  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

^b GEORGETOWN UNIVERSITY   (United States)

Author keywords

Chemomigration; EGF; Prostate cancer; Stroma

Indexed keywords

ALPHA2A INTERFERON; CHEMOATTRACTANT; CYTOKINE; EPIDERMAL GROWTH FACTOR; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 1ALPHA; INTERLEUKIN 2; INTERLEUKIN 6; LYMPHOTOXIN; SECRETORY PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ARTICLE; BONE METASTASIS; CELL MIGRATION; CHEMOKINESIS; EWING SARCOMA; HUMAN; HUMAN CELL; IMMUNOBLOTTING; LEUKEMIA CELL; LYMPH NODE METASTASIS; MALE; OSTEOSARCOMA CELL; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROSTATE TUMOR; STROMA CELL;

BONE AND BONES; BONE NEOPLASMS; CHEMOTACTIC FACTORS; CHEMOTAXIS; CYTOKINES; DOSE-RESPONSE RELATIONSHIP, DRUG; EPIDERMAL GROWTH FACTOR; FLUORESCENT ANTIBODY TECHNIQUE; HUMANS; IMMUNOBLOTTING; LYMPH NODES; LYMPHATIC METASTASIS; MALE; PELVIS; PROSTATE; PROSTATIC NEOPLASMS; TUMOR CELLS, CULTURED;

EID: 0030063104     PISSN: 02704137     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0045(199601)28:1<1::AID-PROS1>3.0.CO;2-L     Document Type: Article

References (32)

1. Saitoh H, Hida M, Shimbo T, Nakamura K, Yamagata J, Satah T: Metastatic patterns of prostatic cancer. Correlation between sites and number of organs involved. Cancer 54:3078-3084, 1984.
2. Orr FW, Kostenuik P, Sanchez-Sweatman OH, Singh G: Mechanisms involved in the metastasis of cancer to the bone. Breast Cancer Res Treat 25:151-163, 1993.
3. Resnick MI: Hemodynamics of prostate bone metastasis. In Karr JP, Yamanaka H (eds): "Prostate Cancer and Bone Metastasis." New York: Plenum Press, 1992, pp 77-81.
4. Paget S: The distribution of secondary growths in cancer of the breast. Lancet 1:571-573, 1889.
5. Hujanen ES, Terranova VP: Migration of tumor cells to organ-derived chemoattractants. Cancer Res 45:3517-3521, 1985.
6. Batson OV: The role of vertebral veins and their role in the spread of metastases. Ann Surg 112:138-149, 1940.
7. Batson OV: The function of vertebral veins in metastatic processes. Ann Intern Med 16:38-45, 1942.
8. Shevrin DH, Kukreja SC, Ghosh L, Lad TE: The development of skeletal metastasis by human prostate cancer in athymic nude mice. Clin Exp Metastasis 6:4014-409, 1988.
9. Geldof AA, Rao BR: Factors in prostate cancer metastasis. Anticancer Res 10:1303-1306, 1990.
10. Nicolson GL: Organ specificity of tumor metastasis: Role of preferential adhesion, invasion and growth of malignant cells at specific secondary sites. Cancer Metastasis Rev 7:143-188, 1988.
11. Haq M, Goltzman D, Tremblay G, Brodt P: Rat prostate adenocarcinoma cells disseminate to bone and adhere preferentially to bone marrow-derived endothelial cells. Cancer Res 52:4613-4619, 1992.
12. Chackal-Roy M, Niemeyer C, Moore M, Zetter R: Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow. J Clin Invest 84:43-50, 1989.
13. Djakiew D, Pflug BR, Delsite M, Lynch JH, Arand G, Thompson EW: Chemotaxis and chemokinesis of human prostate tumor cell lines in response to human prostate stromal cell secretory proteins containing a nerve growth factor-like protein. Cancer Res 53:1416-1420, 1993.
14. Djakiew D, Delsite R, Pflug B, Wrathall J, Lynch JH, Onoda M: Regulation of growth by a nerve growth factor-like protein which modulates paracrine interactions between a neoplastic epithelial cell line and stromal cells of the human prostate. Cancer Res 51:3304-3310, 1991.
15. Gillies RJ, Didier N, Denton M: Determination of cell number in monolayer cultures. Anal Biochem 159:109-113, 1976.
16. Story MT, Jacobs SC, Lawson RK: Epidermal growth factor is not the major growth-promoting agent in extracts or prostatic tissue. J Urol 130:175-179, 1983.
17. Jacobs S, Story MT, Sasse J, Lawson RK: Characterization of a growth factor derived from the rat ventral prostate. J Urol 139:1106-1110, 1988.
18. Harper ME, Goddard L, Glynne-Jones E, Wilson DW, Price-Thomas M, Peeling WB, Griffiths K: An immunocytochemical analysis of TGFα expression in benign and malignant prostatic tumors. Prostate 23:9-23, 1993.
19. Hofer DR, Sherwood ER, Bromberg WD, Mendelsohn J, Lee C, Kozlowski JM: Autonomous growth of androgen-independent human prostatic carcinoma cells: Role of transforming growth factor-α. Cancer Res 51:2780-2785, 1991.
20. Wilding G, Valverius E, Knabbe C, Gelmann EP: Role of transforming growth factor-α in human prostate cancer cell growth. Prostate 15:1-12, 1989.
21. Fong C-J, Sherwood ER, Mendelson J, Lee C, Kozlowski JM: Epidermal growth factor receptor monoclonal antibody inhibits constitutive receptor phosphorylation, reduces autonomous growth, and sensitizes androgen-independent prostatic carcinoma cells to tumor necrosis factor-α. Cancer Res 52:5887-5892, 1992.
22. Jarrard DF, Blitz BF, Smith RC, Patai BL, Rukstalis DB: Effect of epidermal growth factor on prostate cancer cell line PC3 growth and invasion. Prostate 24:46-53, 1994.
23. Jones EG, Harper ME: Studies on the proliferation, secretory activities, and epidermal growth factor receptor expression in benign prostatic hyperplasia explant cultures. Prostate 20:133-149, 1992.
24. Tillotson JK, Rose DP: Density-dependent regulation of epidermal growth factor receptor expression in DU-145 human prostate cancer cells. Prostate 19:53-61, 1991.
25. Connolly JM, Rose DP: Secretion of epidermal growth factor and related polypeptides by the DU 145 human prostate cancer cell line. Prostate 15:177-186, 1989.
26. Connolly JM, Rose DP: Production of epidermal growth factor and transforming growth factor-α by the androgen-responsive LNCaP human prostate cancer cell line. Prostate 16:209-218, 1990.
27. Stoker M, Gherardi E: Regulation of cell movement; the motogenic cytokines. Biochim Biophys Acta 1072:81-102, 1991.
28. Royce LS, Baum BJ: Physiologic levels of salivary epithelial growth factor stimulate migration of an oral epithelial cell line. Biochim Biophys Acta 1092:401-403, 1991.
29. Burgess AW: Epidermal growth factor and transforming growth factor-α. Br Med Bull 45:401-424, 1989.
30. Sarret Y, Woodley DT, Grigsby K, Wynn K, O'Keefe E: Human keratinocyte locomotion: Effect of selected cytokines. J Invest Dermatol 98:12-16, 1992.
31. Grotendorst GR, Soma Y, Takehara K, Charette M: EGF and TGF-alpha are potent chemoattractants for endothelial cells, and EGF-like peptides are present at sites of tissue regeneration. J Cell Physiol 139:617-623, 1989.
32. Adelmann-Grill BC, Wach F, Cully Z, Hein R, Kreig T: Chemotactic migration of normal dermal fibroblasts towards epidermal growth factor and its modulation by platelet-derived growth factor and transforming growth factor-beta. Eur J Cell Biol 51:322-326, 1990.